Erypeg 30 Mg Injection

Product Description

Product introduction

Erypeg 30 Injection is a medicine used in the treatment of anemia due to chronic kidney disease and cancer chemotherapy. It works by stimulating the stem cells of the bone marrow to increase red blood cell production. At the same time, it acts on red blood cells to protect them against destruction.

Erypeg 30 Injection is generally given by a doctor or a nurse. Do not self-administer this medicine at home. The dose depends on your body weight and the cause of your anemia. Get the injection regularly until you complete the dose. Iron supplements both before and during treatment may make this treatment more effective.

How Erypeg 30 Mg Injection Works

Erypeg contains Pegfilgrastim, a biologic agent that stimulates the bone marrow to produce more white blood cells. This action helps to reduce the risk of neutropenia-a dangerous drop in white blood cell count-that can occur in patients undergoing chemotherapy. By supporting immune function, Erypeg aids in minimizing infection risks during cancer treatment.


Usage and Administration Guidelines

Erypeg is administered as a single subcutaneous injection (under the skin) per chemotherapy cycle, as prescribed by a qualified physician. The prefilled syringe with needle is user-friendly, but the injection should be given by healthcare professionals or under medical supervision to ensure proper technique and reduce the risk of complications.


Storage and Handling Instructions

To maintain its efficacy, Erypeg 30 Mg Injection must be stored in a refrigerator between 2C and 8C. Do not freeze the product, as it can degrade the effectiveness of the medication. Keep the syringe in its original packaging until use, and protect it from light. Always follow the manufacturer's recommendations and consult your healthcare provider for specific guidance.